First Wave BioPharma Analyst Ratings
BenzingaMar 25 06:42 ET
First Wave BioPharma Analyst Ratings
BenzingaMar 15 09:47 ET
Roth MKM Maintains Buy on First Wave BioPharma, Adjusts Price Target To $40
BenzingaJan 3 13:16 ET
Buy Rating Affirmed for First Wave BioPharma Amid Strategic Focus on Celiac Treatment
TipRanksJan 2 16:55 ET
Roth MKM Reiterates Buy on First Wave BioPharma, Maintains $11 Price Target
BenzingaSep 19, 2023 09:23 ET
First Wave BioPharma Analyst Ratings
BenzingaSep 19, 2023 09:22 ET
First Wave BioPharma Analyst Ratings
BenzingaJul 14, 2023 06:15 ET
HC Wainwright & Co. Reiterates Buy on First Wave BioPharma, Maintains $10 Price Target
BenzingaJun 29, 2023 06:14 ET
What 4 Analyst Ratings Have To Say About First Wave BioPharma
BenzingaJun 13, 2023 12:00 ET
HC Wainwright Adjusts First Wave BioPharma Price Target to $10 From $14, Maintains Buy Rating
MT NewswiresMay 15, 2023 07:41 ET
HC Wainwright & Co. Reiterates Buy on First Wave BioPharma, Maintains $14 Price Target
BenzingaApr 26, 2023 06:15 ET
HC Wainwright & Co. Maintains Buy on First Wave BioPharma, Lowers Price Target to $14
BenzingaApr 5, 2023 06:34 ET
HC Wainwright & Co. Reiterates Buy on First Wave BioPharma, Maintains $18 Price Target
BenzingaMar 9, 2023 08:59 ET
First Wave BioPharma Analyst Ratings
Benzinga Analyst RatingsFeb 3, 2023 06:13 ET
HC Wainwright & Co. Reiterates Buy on First Wave BioPharma, Maintains $18 Price Target
Benzinga Real-time NewsFeb 3, 2023 06:13 ET
First Wave BioPharma Analyst Ratings
Benzinga Analyst RatingsJan 31, 2023 11:42 ET
HC Wainwright & Co. Reiterates Buy on First Wave BioPharma, Maintains $18 Price Target
Benzinga Real-time NewsJan 31, 2023 11:42 ET
First Wave BioPharma Analyst Ratings
Benzinga Analyst RatingsJan 26, 2023 13:26 ET
First Wave BioPharma Analyst Ratings
Benzinga Analyst RatingsDec 2, 2022 05:08 ET
HC Wainwright & Co. Maintains Buy on First Wave BioPharma, Lowers Price Target to $4
Benzinga Real-time NewsDec 2, 2022 05:08 ET
No Data
No Data